PT BRIGHTGENE BIOMEDCIAL INDONESIA

Company Type: Trading Company (specifically, a distributor and sales office for its parent manufacturing company, BrightGene Bio-Medical Technology Co., Ltd. based in China).

Company Profile:

PT BRIGHTGENE BIOMEDICAL INDONESIA is the Indonesian subsidiary of BrightGene Bio-Medical Technology Co., Ltd., a pharmaceutical company originating from China with a strong focus on research and development. The Indonesian entity's primary role is to manage the sales, marketing, and distribution of high-quality pharmaceutical products and services throughout Indonesia. It functions as the local arm to ensure the availability of its parent company's innovative medicines and healthcare solutions in the Indonesian market. While its parent company, BrightGene Bio-Medical Technology Co., Ltd., is a manufacturer with extensive capabilities in pharmaceutical research, development, and production, PT BRIGHTGENE BIOMEDICAL INDONESIA focuses on market penetration, customer relations, and business development within the Indonesian healthcare sector.

Based on available information, PT BRIGHTGENE BIOMEDICAL INDONESIA manufactures and/or distributes the following products:

* COVID-19 Test Kits (including PCR and Antigen tests)

* Molecular Biology Reagents

* Medical Devices

* Diagnostic Equipment